20h
MedPage Today on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
Cutting government waste is a good aim, but we need a bold new vision and priorities to tackle the drug crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results